[Retracted] Effects of Apatinib Mesylate Monotherapy on the Incidence of Adverse Reactions and Immune Function in Patients with Breast Cancer after Radical Mastectomy
Table 4
Comparison of T-cell subsets and NK cells (± s).
Groups
Timepoints
Conventional group (n = 45)
Study group (n = 45)
t
CD4+
Preoperatively
80.45 ± 5.28
80.39 ± 6.01
0.050
0.960
1 week postoperatively
58.35 ± 5.12
69.13 ± 6.21
8.985
<0.001
4 weeks postoperatively
69.88 ± 5.35
80.02 ± 5.98
8.477
<0.001
CD8+
Preoperatively
25.88 ± 3.63
25.92 ± 3.45
0.054
0.957
1 week postoperatively
40.25 ± 3.02
35.13 ± 2.68
8.506
<0.001
4 weeks postoperatively
35.12 ± 3.44
30.08 ± 3.18
7.217
<0.001
CD4+/CD8+
Preoperatively
1.86 ± 0.24
1.88 ± 0.17
0.456
0.650
1 week postoperatively
0.88 ± 0.02
1.24 ± 0.17
14.108
<0.001
4 weeks postoperatively
1.23 ± 0.28
1.72 ± 0.35
7.334
<0.001
NK
Preoperatively
18.24 ± 3.03
18.21 ± 3.14
0.046
0.963
1 week postoperatively
12.24 ± 2.15
14.96 ± 2.14
6.015
<0.001
4 weeks postoperatively
15.02 ± 2.16
18.08 ± 2.58
6.101
<0.001
Note. indicates no statistically significant differences at 4 weeks postoperatively ().
